DAWN vs DKNG · rev $131.2M vs rev $6.05B
Day One Biopharmaceuticals Inc (DAWN) versus DraftKings Inc (DKNG) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
DraftKings Inc (DKNG) is a gambling company listed on US.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported DKNG revenue for 2025-12-31 was $6.05B. Net income was $3.7M. Revenue was up 27.0% from 2024-12-31 to 2025-12-31. DKNG currently screens at market cap $20.96B.
DAWN currently screens at market cap $656.8M. DKNG currently screens at market cap $20.96B.
Not investment advice. Open the DAWN and DKNG stock pages for the full models.
Not investment advice.